TL;DR
A growing body of epidemiological evidence indicates that patients with IBD carry an elevated risk of cardiovascular events, including coronary artery disease, stroke, heart failure (HF), venous thromboembolism (VTE)
Inflammatory bowel disease (IBD) — ulcerative colitis (UC) and Crohn's disease (CD) — comprises chronic, immune-mediated disorders of the gastrointestinal tract whose pathophysiological impact extends beyond the intestinal mucosa. A growing body of epidemiological evidence, including large-scale meta-analyses, indicate...
Cumulative evidence supports the role of the intestinal epithelial barrier, immune system and gut microbiota in the progression of Crohn's disease.
Inflammatory bowel disease (IBD), comprising Crohn’s disease and ulcerative colitis, is a chronic relapsing intestinal inflammatory disorder. Cardiovascular disease (CVD) is a leading cause of death in patients with IBD, with elevated risks of myocardial infarction, heart failure, stroke, and venous thromboembolism tha...
Introduction: Inflammatory bowel disease (IBD) is an umbrella term encompassing two major chronic immune-mediated disorders, Crohn’s disease (CD) and ulcerative colitis (UC). Its pathogenesis reflects complex interactions among genetic, microbial, metabolic, environmental, and immune factors. Growing evidence supports...
Inflammatory bowel disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis, is a growing global health challenge, with approximately 25% of cases diagnosed before the age of 20. These chronic immune- mediated disorders result from complex interactions between genetic predisposition, environmental triggers...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
